Mark Leschly

Mark Leschly

Director/Board Member chez CHARGEPOINT HOLDINGS, INC.

Fortune : 908 439 $ au 31/03/2024

55 ans
Health Technology
Finance
Technology Services

Profil

Mark Leschly is the founder and currently holds the position of Director at MMAX Investment Partners, Inc. which was founded in 2017.
He is also currently the Chairman & Chief Executive Officer at Universal Tennis LLC, Chairman & Chief Executive Officer at Universal Tennis Management LLC, Director at ChaCha Search, Inc., Director at Fabletics, Inc., Director at Tapjoy, Inc., Director at Greenfly, Inc., Managing Director at Iconica LLC, Independent Director at ChargePoint Holdings, Inc. since 2009, Director at Professional Fighters League LLC, Managing Partner at Rho Capital since 1999, Managing Partner at Rho Capital Partners, Inc. since 1999, Managing Partner at Rho Fund Investors since 1999, and Manager Member & Owner at Iconia LLC since 2014.
Mr. Leschly's former positions include Chairman at Senomyx, Inc. from 2001 to 2008, Director at NetMed, Inc., Director at Vicuron Pharmaceuticals LLC, Director at NitroMed, Inc., Director at Tercica, Inc. from 2003 to 2008, Director at Medical Present Value, Inc., Director at Vanda Pharmaceuticals, Inc., Director at Gloucester Pharmaceuticals, Inc., Director at Slacker, Inc., Independent Director at NGM Biopharmaceuticals, Inc. from 2008 to 2022, Managing Director at HealthCare Ventures LLC from 1994 to 1999, Director at Broadlogic Network Technologies, Inc., Director at Memory Pharmaceuticals Corp., Director at Medpace Research, Inc., Director at Orqis Medical Corp., Independent Director at Anacor Pharmaceuticals LLC from 2002 to 2016, Director at National Venture Capital Association, Director at Verenium Corp.
from 1999 to 2009, Director at ChargePoint, Inc., and Principal at McKinsey & Co., Inc.Mr. Leschly's education includes an undergraduate degree from Harvard University and an MBA from Stanford Graduate School of Business.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
18/07/2023 478 126 ( 0,11% ) 908 439 $ 31/03/2024
31/12/2022 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Mark Leschly

SociétésPosteDébut
CHARGEPOINT HOLDINGS, INC. Director/Board Member 01/12/2009
Private Equity Investor 01/01/1999
Founder 01/01/2017
Director/Board Member 26/10/2010
Director/Board Member -
Chief Executive Officer -
Private Equity Investor -
Director/Board Member -
Director/Board Member -
Tous les postes actifs de Mark Leschly

Anciens postes connus de Mark Leschly

SociétésPosteFin
░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Mark Leschly

Formation de Mark Leschly

Harvard University Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark Leschly

Relations

100 +

Relations au 1er degré

35

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
NETMED, INC.

Health Technology

VANDA PHARMACEUTICALS INC.

Health Technology

NGM BIOPHARMACEUTICALS, INC.

Health Technology

Entreprise privées30

Health Technology

Finance

Consumer Non-Durables

Health Technology

Health Technology

Technology Services

Health Technology

Technology Services

Technology Services

Technology Services

Finance

Commercial Services

Electronic Technology

Finance

Health Technology

Distribution Services

Health Services

Finance

Health Technology

Commercial Services

Health Technology

Producer Manufacturing

Technology Services

Iconia LLC

Commercial Services

Technology Services

Finance

Finance

Distribution Services

ChargePoint Holdings, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mark Leschly